{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:57:58Z","timestamp":1790647078972,"version":"4.1.0"},"reference-count":189,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.critrevonc.2004.05.006","type":"journal-article","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T18:22:43Z","timestamp":1090434163000},"page":"141-164","source":"Crossref","is-referenced-by-count":68,"title":["Germ cell tumours of the testis"],"prefix":"10.1016","volume":"53","author":[{"given":"Stefania","family":"Gori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Porrozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Roila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"De Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Marangolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2004.05.006_BIB1","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality and prevalence worldwide, Version 1.0. IARC Cancer Base No. 5. Lyon: IARC Press, 2001."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB2","unstructured":"Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. VIII. IARC Scientific Publications No. 155. Lyon: International Agency for Research on Cancer, 2002."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB3","unstructured":"ENCR. European Network of Cancer Registries, Eurocim Version 4.0. European Incidence Database V2.2, 1999. Lyon, 2001."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB4","unstructured":"Coleman MP, Babb P, Daniecki P, et al. Cancer survival trends in England and Wales, 1971\u20131995: deprivation and NHS region. Studies in medical and population subjects No. 61. London: The Stationary Office, 1999."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/jech.41.4.349","article-title":"Testicular cancer in young men: the search for causes of the epidemic increase in the United States","volume":"41","author":"Brown","year":"1987","journal-title":"J. Epidemiol. Commun Health"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1289\/ehp.5446","article-title":"Temporal trends in orchidopexy, Great Britain, 1992\u20131998","volume":"111","author":"Toledano","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB7","doi-asserted-by":"crossref","unstructured":"Berrino F. The EUROCARE study: strengths, limitations and perspectives of population-based, comparative survival studies. Ann Oncol 2003;14(Suppl 5):V9\u201313.","DOI":"10.1093\/annonc\/mdg750"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB8","doi-asserted-by":"crossref","unstructured":"Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14(Suppl 5):V128\u201349.","DOI":"10.1093\/annonc\/mdg756"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/028418699432996","article-title":"Survival of cancer patients in Finland 1955\u20131994","volume":"38 Suppl 12","author":"Dickman","year":"1999","journal-title":"Acta Oncol"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB10","doi-asserted-by":"crossref","unstructured":"Gatta G, Corazziari I, Magnani C, Peris-Bonet R, Roazzi P, Stiller C. Childhood cancer survival in Europe. Ann Oncol 2003;14(Suppl 5):V119\u201327.","DOI":"10.1093\/annonc\/mdg755"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB11","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.ejca.2003.09.004","article-title":"Cancer survival in European adolescents and young adults","volume":"39","author":"Gatta","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/030089169908500502","article-title":"Cancer prevalence in Italian cancer registry areas: the ITAPREVAL study. ITAPREVAL Working Group","volume":"85","author":"Micheli","year":"1999","journal-title":"Tumori"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB13","first-page":"1151","article-title":"Estrogen exposure during gestation and risk of testicular cancer","volume":"71","author":"Depue","year":"1983","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ijc.2910230503","article-title":"Risk factors for cancer of the testis in young men","volume":"23","author":"Henderson","year":"1979","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/oxfordjournals.aje.a114877","article-title":"Cryptorchism, orchiopexy, and the risk of testicular cancer","volume":"127","author":"Strader","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB16","unstructured":"Bernstein L, et al. Germ cell, trophoblastic and other gonadal neoplasms ICCC X. In: Ries LAG, et al., editors. Cancer incidence and survival among children and adolescents: United States SEER program 1975\u20131995. National Cancer Institute, SEER Program. Bethesda, MD: NIH Publications No. 99-4649, 1999."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jech.36.2.96","article-title":"Prenatal factors in the aetiology of testicular cancer: an epidemiological study of childhood testicular cancer deaths in Great Britain, 1953\u201373","volume":"36","author":"Swerdlow","year":"1982","journal-title":"J Epidemiol Commun Health"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB18","first-page":"4812","article-title":"Prenatal and perinatal risk factors for testicular cancer","volume":"46","author":"Brown","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF00051790","article-title":"An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States)","volume":"6","author":"Shu","year":"1995","journal-title":"Cancer Causes Contr"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0090-4295(83)80015-6","article-title":"Father-son testicular (teratocarcinoma) malignancy","volume":"22","author":"Klein","year":"1983","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000226513","article-title":"Inheritance and testicular cancer. Arguments based on a report of 3 cases and a review of the literature","volume":"44","author":"Dieckmann","year":"1987","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/oxfordjournals.aje.a115319","article-title":"The epidemiology of testicular cancer in upstate, New York","volume":"130","author":"Haughey","year":"1989","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/bjc.1987.20","article-title":"Testicular cancer and antecedent diseases","volume":"55","author":"Swerdlow","year":"1987","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/oxfordjournals.aje.a114958","article-title":"Vasectomy and the incidence of testicular cancer","volume":"128","author":"Strader","year":"1988","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajim.4700190307","article-title":"Occupation and the occurrence of testicular cancer","volume":"19","author":"Van den Eeden","year":"1991","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB26","unstructured":"Stewart BW, Kleihus P, editors. World cancer report. Lyon: IARC Press, 2003."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/aje\/153.4.309","article-title":"First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada","volume":"153","author":"Sont","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB28","first-page":"89","article-title":"Relationships between occupational exposure and cancer of the testis","volume":"153","author":"Faroy-Menciere","year":"2002","journal-title":"Ann. Med. Int. (Paris)"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ijc.10332","article-title":"Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database","volume":"99","author":"Czene","year":"2002","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/bmj.321.7264.789","article-title":"Risk of testicular cancer in men with abnormal semen characteristics: cohort study","volume":"321","author":"Jacobsen","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0094-0143(21)01352-5","article-title":"Carcinoma-in-situ of the undescended testis","volume":"9","author":"Skakkebaek","year":"1982","journal-title":"Urol. Clin. N. Am."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB32","first-page":"1475","article-title":"Genetics and biology of adult human male germ cell tumors","volume":"60","author":"Chaganti","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB33","unstructured":"Dixon RJ, Moore RA, editors. Atlas of tumor pathology, Fascicle 31B, Section 8. Washington, DC: Armed Forces Institute of Pathology, 1952."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB34","unstructured":"Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, editors. ICD-O: International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization, 2000."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000478-198701000-00003","article-title":"Placental alkaline phosphatase immunoreactivity in testicular germ-cell neoplasms","volume":"11","author":"Manivel","year":"1987","journal-title":"Am. J. Surg Pathol"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/path.1711770307","article-title":"Differential expression of the c-kit proto-oncogene in germ cell tumours","volume":"177","author":"Izquierdo","year":"1995","journal-title":"J. Pathol"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB37","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/1097-0142(19840901)54:5<843::AID-CNCR2820540514>3.0.CO;2-G","article-title":"Antikeratin antibodies in tumor diagnosis. Distinction between seminoma and embryonal carcinoma","volume":"54","author":"Battifora","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB38","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF00337825","article-title":"Serum lactate dehydrogenase (S-LDH) and S-LDH isoenzymes in patients with testicular germ cell tumors","volume":"189","author":"von Eyben","year":"1983","journal-title":"Mol. Gen. Genet."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1464-410X.2002.02641.x","article-title":"The role of (18)fluoro-2-deoxyglucose positron emission tomography in initial staging and re-staging after chemotherapy for testicular germ cell tumours","volume":"89","author":"Spermon","year":"2002","journal-title":"BJU Int"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB40","unstructured":"UICC (International Union Against Cancer). In: Sobin LH, Wittekind Ch, editors. TNM classification of malignant tumours. 6th ed. New York: Wiley\u2013Liss., 2002."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1200\/JCO.1986.4.3.400","article-title":"Prognostic factors for favorable outcome in disseminated germ cell tumors","volume":"4","author":"Birch","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB42","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/bjc.1995.254","article-title":"Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group","volume":"71","author":"de Wit","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB43","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1200\/JCO.1988.6.5.786","article-title":"Comparison of criteria for assigning germ cell tumor patients to \u201cgood risk\u201d and \u201cpoor risk\u201d studies","volume":"6","author":"Bajorin","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB44","doi-asserted-by":"crossref","unstructured":"IGCCCG. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997;594\u2013603.","DOI":"10.1200\/JCO.1997.15.2.594"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB45","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0022-5347(01)67617-1","article-title":"A review of scrotal violation in testicular cancer: is adjuvant local therapy necessary?","volume":"153","author":"Capelouto","year":"1995","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB46","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/0090-4295(83)90190-5","article-title":"Impact of symptomatic interval on prognosis of patients with stage III testicular cancer","volume":"21","author":"Scher","year":"1983","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB47","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(81)91165-X","article-title":"Impact of delay in diagnosis on clinical stage of testicular cancer","volume":"2","author":"Bosl","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0360-3016(92)90977-P","article-title":"Brain metastases and testicular tumors: long-term survival","volume":"22","author":"Spears","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2605.1987.tb00186.x","article-title":"Management of carcinoma-in-situ of the testis","volume":"10","author":"von der Maase","year":"1987","journal-title":"Int. J. Androl."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB50","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1210\/jcem-73-3-596","article-title":"Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients","volume":"73","author":"Giwercman","year":"1991","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB51","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0022-5347(05)65526-7","article-title":"Organ sparing surgery for malignant germ cell tumor of the testis","volume":"166","author":"Heidenreich","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1159\/000020055","article-title":"Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group","volume":"36","author":"Weissbach","year":"1999","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB53","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.1999.17.4.1146","article-title":"Optimal planning target volume for stage I testicular seminoma: A medical research council randomized trial. Medical Research Council Testicular Tumor Working Group","volume":"17","author":"Fossa","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB54","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<823::AID-IJC22>3.0.CO;2-V","article-title":"Radiotherapy for stages I and IIA\/B testicular seminoma","volume":"83","author":"Bamberg","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0936-6555(05)80087-1","article-title":"Short duration radiotherapy in stage I seminoma of the testis: preliminary results of a prospective study","volume":"5","author":"Read","year":"1993","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0167-8140(95)01631-P","article-title":"Low-dose radiotherapy for stage I seminoma: early results","volume":"37","author":"Niewald","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB57","first-page":"188a","article-title":"Quality of life (QL) after radiotherapy (RT) for stage I seminoma: results from a randomised trial of two RT schedules (MRC TE18)","volume":"21","author":"Fossa","year":"2002","journal-title":"Proc. ASCO"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB58","unstructured":"Fossa SD. Management of clinical stage I seminoma. In: Alexandria VA, MC Perry, editors. American society of clinical oncology\u2014educational book, 2003. p. 131\u20135."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0360-3016(94)90219-4","article-title":"Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy","volume":"29","author":"Oliver","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01203075","article-title":"Adjuvant carboplatin treatment for seminoma clinical stage I","volume":"122","author":"Dieckmann","year":"1996","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB61","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.1995.13.9.2255","article-title":"Stage I testicular seminoma: results of adjuvant irradiation and surveillance","volume":"13","author":"Warde","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB62","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1016\/0959-8049(93)90446-M","article-title":"Surveillance following orchidectomy for stage I seminoma of the testis","volume":"29A","author":"von der Maase","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB63","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bjc.1992.164","article-title":"Surveillance following orchidectomy for stage I testicular seminoma","volume":"65","author":"Horwich","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB64","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB65","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0094-0143(21)00166-X","article-title":"Radiation therapy: a primary treatment modality for seminoma","volume":"7","author":"Stutzman","year":"1980","journal-title":"Urol. Clin. N. Am."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB66","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/0360-3016(81)90038-9","article-title":"Patterns of care outcome studies: results of the national practice in seminoma of the testis","volume":"7","author":"Hanks","year":"1981","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0360-3016(82)90509-0","article-title":"Seminoma of the testis: results of treatment and patterns of failure after radiation therapy","volume":"8","author":"Thomas","year":"1982","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB68","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/0360-3016(85)90030-6","article-title":"Seminoma of the testis: a 22-year experience with radiation therapy","volume":"11","author":"Willan","year":"1985","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-8140(86)80195-5","article-title":"Results of radiotherapy for stage II testicular seminoma","volume":"6","author":"Gregory","year":"1986","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB70","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1200\/JCO.1998.16.1.290","article-title":"Management of stage II seminoma","volume":"16","author":"Warde","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB71","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0360-3016(88)90450-6","article-title":"Seminoma with bulky abdominal disease","volume":"14","author":"Zagars","year":"1988","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB72","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1200\/JCO.1988.6.12.1856","article-title":"Radiotherapy for stage 2 testicular seminoma: the prognostic influence of tumor bulk","volume":"6","author":"Mason","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB73","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.1996.14.2.454","article-title":"Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center","volume":"14","author":"Puc","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB74","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-5347(01)65065-1","article-title":"Surgery for a post-chemotherapy residual mass in seminoma","volume":"157","author":"Herr","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB75","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1200\/JCO.1996.14.10.2884","article-title":"Optimal management of residual mass after chemotherapy in advanced seminoma: there is time for everything","volume":"14","author":"Culine","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB76","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0959-8049(97)00033-6","article-title":"Radiotherapy after chemotherapy for metastatic seminoma\u2014a diminishing role. MRC Testicular Tumour Working Party","volume":"33","author":"Duchesne","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB77","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.1989.7.3.387","article-title":"Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol","volume":"7","author":"Einhorn","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB78","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1200\/JCO.1998.16.2.702","article-title":"Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience","volume":"16","author":"Saxman","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB79","first-page":"309a","article-title":"Is 3BEP equivalent to 3BEP\u20131EP in good prognosis germ cell cancer? an EORTC\/MRC phase III study (meeting abstract)","volume":"18","author":"deWit","year":"1999","journal-title":"Proc. ASCO"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB80","first-page":"309a","article-title":"Are 3 cycles of bleomycin, etoposide and cisplatin (3BEP) or 4 cycles of etoposide and cisplatin (4EP) equivalent regimens for patients (pts) with good-risk metastatic non-seminomatous germ cell tumors (NSGCT)? Preliminary results of a randomized trial (meeting abstract)","volume":"18","author":"Culine","year":"1999","journal-title":"Proc. ASCO"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB81","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1200\/JCO.1998.16.4.1287","article-title":"Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group","volume":"16","author":"Nichols","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1097-0142(19910101)67:1<28::AID-CNCR2820670106>3.0.CO;2-3","article-title":"Two-drug therapy in patients with metastatic germ cell tumors","volume":"67","author":"Bajorin","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB83","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/(SICI)1097-0142(19970501)79:9<1641::AID-CNCR1>3.0.CO;2-F","article-title":"Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease","volume":"79","author":"Heidenreich","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB84","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1990.8.3.509","article-title":"Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish\u2013Norwegian Testicular Cancer Group","volume":"8","author":"Klepp","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB85","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(87)90889-0","article-title":"Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone","volume":"2","author":"Freedman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB86","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1200\/JCO.2000.18.2.358","article-title":"Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma\u2014predominant testis cancer","volume":"18","author":"Sweeney","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB87","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0959-8049(05)80220-5","article-title":"Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A review","volume":"29A","author":"Droz","year":"1993","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB88","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1200\/JCO.2003.01.094","article-title":"Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review","volume":"21","author":"Vergouwe","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-5347(17)32830-6","article-title":"The management of patients with nonseminomatous germ cell tumors of the testis with serologic disease only after orchiectomy","volume":"152","author":"Davis","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB90","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-5347(17)36046-9","article-title":"Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation","volume":"149","author":"Donohue","year":"1993","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB91","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-5347(17)53996-8","article-title":"Ejaculation and fertility after extended retroperitoneal lymph node dissection for testicular cancer","volume":"127","author":"Narayan","year":"1982","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000463504","article-title":"Unilateral retroperitoneal lymph node dissection in patients with non-seminomatous testicular tumor in clinical stage I","volume":"10","author":"Fossa","year":"1984","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB93","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0022-5347(17)32523-5","article-title":"The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection","volume":"152","author":"Foster","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB94","first-page":"166","article-title":"Surgical treatment of clinical stage A nonseminomatous testis cancer","volume":"19","author":"Foster","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB95","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0094-0143(05)70035-5","article-title":"Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques","volume":"25","author":"Donohue","year":"1998","journal-title":"Urol. Clin. N. Am."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB96","first-page":"264","article-title":"Fertility issues following therapy for testicular cancer","volume":"2","author":"Lange","year":"1984","journal-title":"Semin. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB97","first-page":"15","article-title":"Clinical stage I testis tumors: the medical oncologist\u2019s view","volume":"66","author":"Williams","year":"1982","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB98","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0022-5347(01)65718-5","article-title":"Laparoscopic retroperitoneal lymph node dissection for nonseminomatous germ cell tumors: indications and limitations","volume":"156","author":"Rassweiler","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB99","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/PL00007075","article-title":"Laposcopic retroperitoneal lymph node dissection: evolution of a new technique","volume":"18","author":"Janetschek","year":"2000","journal-title":"World J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB100","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.1995.13.5.1188","article-title":"Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience","volume":"13","author":"Gels","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB101","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1200\/JCO.1992.10.11.1762","article-title":"Medical research council prospective study of surveillance for stage I testicular teratoma. Medical research council testicular tumors working party","volume":"10","author":"Read","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB102","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0022-5347(01)66972-6","article-title":"A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup","volume":"154","author":"Nicolai","year":"1995","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB103","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1097-0142(19880915)62:6<1202::AID-CNCR2820620627>3.0.CO;2-S","article-title":"Clinical stage I nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone","volume":"62","author":"Dunphy","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB104","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0022-5347(01)63753-4","article-title":"Clinical stage I testis cancer: long-term outcome of patients on surveillance","volume":"159","author":"Sogani","year":"1998","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-5347(17)34874-7","article-title":"Primary chemotherapy for stage II nonseminomatous germ cell tumors of the testis","volume":"151","author":"Horwich","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB106","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0022-5347(01)65476-4","article-title":"Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer","volume":"156","author":"Coogan","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB107","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.1991.9.9.1543","article-title":"Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group","volume":"9","author":"Rorth","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0090-4295(91)80007-T","article-title":"Clinical stage I nonseminomatous germ cell tumors of testis. Observation vs retroperitoneal lymph node dissection","volume":"38","author":"Sujka","year":"1991","journal-title":"Urology"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB109","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1200\/JCO.1992.10.4.564","article-title":"Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors","volume":"10","author":"Sturgeon","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB110","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0959-8049(00)00442-1","article-title":"Stage I non-seminomatous germ-cell tumours of the testis: identification of a subgroup of patients with a very low risk of relapse","volume":"37","author":"Alexandre","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB111","first-page":"362","article-title":"Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer","volume":"54","author":"Moul","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB112","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/JCO.1998.16.1.261","article-title":"Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment","volume":"16","author":"Leibovitch","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB113","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1200\/JCO.1996.14.4.1106","article-title":"Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a medical research council report","volume":"14","author":"Cullen","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB114","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1996.14.2.441","article-title":"Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial","volume":"14","author":"Pont","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB115","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0094-0143(21)00165-8","article-title":"Is adjuvant chemotherapy following retroperitoneal lymph node dissection for nonseminomatous testis cancer necessary","volume":"7","author":"Donohue","year":"1980","journal-title":"Urol. Clin. N. Am."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB116","first-page":"308a","article-title":"Elevated ([up arrow]) serum tumor markers (STM) prior to 1 [deg] RPLND predicts clinical outcome and requirements for systemic chemotherapy in patients with PN1, N2 and N3 nonseminomatous germ cell tumor (NSGCT) (meeting abstract)","volume":"18","author":"Sheinfeld","year":"1999","journal-title":"Proc. ASCO"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB117","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1200\/JCO.1995.13.5.1170","article-title":"Late relapse of testicular cancer","volume":"13","author":"Baniel","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB118","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1200\/JCO.1991.9.8.1393","article-title":"Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer","volume":"9","author":"Richie","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB119","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.1992.10.1.69","article-title":"Prognosis and other clinical correlates of pathologic review in stages I and II testicular carcinoma: a report from the Testicular Cancer Intergroup Study","volume":"10","author":"Sesterhenn","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1200\/JCO.1983.1.3.171","article-title":"Stage II nonseminomatous testicular cancer: a 10-year experience","volume":"1","author":"Vogelzang","year":"1983","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB121","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1097-0142(19810715)48:2<233::AID-CNCR2820480204>3.0.CO;2-U","article-title":"Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancer","volume":"48","author":"Vugrin","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB122","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/1097-0142(19830101)51:1<5::AID-CNCR2820510103>3.0.CO;2-J","article-title":"VAB-6 combination chemotherapy in resected stage II-B testis cancer","volume":"51","author":"Vugrin","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB123","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJM198712033172303","article-title":"Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer","volume":"317","author":"Williams","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB124","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1200\/JCO.1995.13.11.2700","article-title":"Etoposide and cisplatin adjuvant therapy for patients with pathologic stage II germ cell tumors","volume":"13","author":"Motzer","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB125","first-page":"382","article-title":"The optimal chemotherapy regimen for good-risk metastatic non-seminomatous germ cell tumors (MNSGCT) is 3 cycles of bleomycin, etoposide and cisplatin: mature results of a randomized trial","volume":"22","author":"Culine","year":"2003","journal-title":"Proc. ASCO"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB126","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1200\/JCO.1995.13.2.470","article-title":"Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial","volume":"13","author":"Loehrer","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB127","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1200\/JCO.1990.8.10.1683","article-title":"Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection","volume":"8","author":"Toner","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1992.10.4.569","article-title":"Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses","volume":"10","author":"Fossa","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB129","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/bjc.1984.226","article-title":"Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma","volume":"50","author":"Tait","year":"1984","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jso.2930380405","article-title":"Results of adjuvant surgery in patients with stages III and IV nonseminomatous testicular tumors after cisplatin\u2013vinblastine\u2013bleomycin chemotherapy","volume":"38","author":"Gelderman","year":"1988","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB131","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/0277-5379(89)90336-2","article-title":"Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours","volume":"25","author":"Harding","year":"1989","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB132","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/bjc.1996.571","article-title":"Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. The ReHiT study group. Re-analysis of histology in testicular cancer","volume":"74","author":"Steyerberg","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB133","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0022-5347(17)46031-9","article-title":"Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation","volume":"135","author":"Loehrer","year":"1986","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB134","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1200\/JCO.1993.11.7.1294","article-title":"Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections","volume":"11","author":"Fox","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB135","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1200\/JCO.2001.19.10.2647","article-title":"Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy\u2014results from an international study group","volume":"19","author":"Fizazi","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB136","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000474596","article-title":"Early intensified chemotherapy with autologous bone marrow transplantation in first line treatment of poor risk non-seminomatous germ cell tumours. Preliminary results of a French randomized trial","volume":"23","author":"Chevreau","year":"1993","journal-title":"Eur. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB137","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1200\/JCO.1998.16.4.1294","article-title":"Management strategies and outcomes of germ cell tumor patients with very high human chorionic gonadotropin levels","volume":"16","author":"Zon","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB138","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1200\/JCO.1997.15.5.1837","article-title":"Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group","volume":"15","author":"de Wit","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB139","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1200\/JCO.2003.02.075","article-title":"Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group\/Medical Research Council Testicular Cancer Study Group (30941\/TE20)","volume":"21","author":"Fossa","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB140","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1200\/JCO.1997.15.5.1844","article-title":"Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multi-institutional Medical Research Council\/European Organization for Research and Treatment of Cancer Trial","volume":"15","author":"Horwich","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB141","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1200\/JCO.1993.11.4.598","article-title":"Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multi-institutional study","volume":"11","author":"Bajorin","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB142","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJM198706043162302","article-title":"Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide","volume":"316","author":"Williams","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB143","first-page":"239","article-title":"Phase III study of cisplatin, etoposide and bleomycin (PVP16B) or etoposide, ifosfamide and cisplatin (VIP) in advanced stage germ cell tumors; an intergroup trial (meeting abstract)","volume":"14","author":"Nichols","year":"1995","journal-title":"Proc. ASCO"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB144","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1200\/JCO.1998.16.2.692","article-title":"Intensive induction-sequential chemotherapy with BOP\/VIP-B compared with treatment with BEP\/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council\/European Organization for Research and Treatment of Cancer study","volume":"16","author":"Kaye","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB145","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.1988.6.6.1031","article-title":"A randomized trial of standard chemotherapy vs a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors","volume":"6","author":"Ozols","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB146","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1991.9.7.1163","article-title":"Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol","volume":"9","author":"Nichols","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB147","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-5347(17)41513-8","article-title":"Metastatic testicular teratoma invading the inferior vena cava","volume":"140","author":"Morgentaler","year":"1988","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB148","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0022-5347(17)32524-7","article-title":"Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy","volume":"152","author":"Little","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB149","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/1097-0142(19810815)48:4<904::AID-CNCR2820480407>3.0.CO;2-O","article-title":"Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction","volume":"48","author":"Einhorn","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB150","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/1097-0142(19860301)57:5<978::AID-CNCR2820570517>3.0.CO;2-9","article-title":"Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors","volume":"57","author":"Tiffany","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB151","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0022-5347(01)66355-9","article-title":"Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors","volume":"155","author":"Leibovitch","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB152","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.1990.8.11.1777","article-title":"Treatment of testicular cancer: a new and improved model","volume":"8","author":"Einhorn","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB153","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.1998.16.7.2500","article-title":"Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor","volume":"16","author":"Loehrer","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB154","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/1097-0142(19901215)66:12<2476::AID-CNCR2820661206>3.0.CO;2-D","article-title":"The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors","volume":"66","author":"Motzer","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1200\/JCO.1997.15.4.1427","article-title":"Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma","volume":"15","author":"Miller","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB156","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1200\/JCO.1994.12.11.2277","article-title":"Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors","volume":"12","author":"Motzer","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB157","unstructured":"Motzer RJ, Green G, McCaffrey J, et al. Paclitaxel (T), ifosfamide (I), and cisplatin (P) as first-line salvage therapy for relapsed germ cell tumor (GCT) patients with favourable prognostic features. Proc ASCO 1998;17:322a."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB158","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1200\/JCO.2000.18.12.2413","article-title":"Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer","volume":"18","author":"Motzer","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB159","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1999.17.2.509","article-title":"Phase II trial of gemcitabine in refractory germ cell tumors","volume":"17","author":"Einhorn","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB160","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1200\/JCO.2002.07.158","article-title":"Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group","volume":"20","author":"Hinton","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB161","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1200\/JCO.2002.08.050","article-title":"Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group","volume":"20","author":"Kollmannsberger","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB162","unstructured":"Rosti G, Pico JL, Wandt H, et al. High-dose chemotherapy (HDC) in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumors (GCT) first results of a prospective randomised trial of the European Group for Blood and Marrow Transplantation (EBMT): IT-94 study. Proc ASCO 2002;21:180a."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB163","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1200\/JCO.1996.14.4.1098","article-title":"High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity","volume":"14","author":"Motzer","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB164","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0959-8049(96)00458-3","article-title":"Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients","volume":"33","author":"Wanderas","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB165","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1200\/JCO.1993.11.3.415","article-title":"Second cancer risk following testicular cancer: a follow-up study of 1909 patients","volume":"11","author":"Van Leeuwen","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB166","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.1995.13.1.283","article-title":"Treatment of testicular cancer and the development of secondary malignancies","volume":"13","author":"Bokemeyer","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB167","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/jnci\/89.19.1429","article-title":"Risk of second malignant neoplasms among long-term survivors of testicular cancer","volume":"89","author":"Travis","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB168","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1200\/JCO.1992.10.4.574","article-title":"Long-term effects of chemotherapy in patients with testicular cancer","volume":"10","author":"Osanto","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB169","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1200\/JCO.1989.7.10.1457","article-title":"Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer","volume":"7","author":"Hansen","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB170","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00262741","article-title":"Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effects","volume":"21","author":"Pollera","year":"1988","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB171","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1200\/JCO.1988.6.11.1728","article-title":"Long-term effects on renal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ cell cancer","volume":"6","author":"Hansen","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB172","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1200\/JCO.1986.4.10.1493","article-title":"VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors","volume":"4","author":"Bosl","year":"1986","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB173","first-page":"1159","article-title":"Coronary artery disease after treatment with bleomycin and vinblastine","volume":"64","author":"Vogelzang","year":"1980","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB174","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1200\/JCO.2000.18.8.1725","article-title":"Cardiovascular morbidity in long-term survivors of metastatic testicular cancer","volume":"18","author":"Meinardi","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB175","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.1992.10.9.1386","article-title":"Hypercholesterolemia after chemotherapy for testis cancer","volume":"10","author":"Raghavan","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB176","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/annonc\/mdf058","article-title":"Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer","volume":"13","author":"Strumberg","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB177","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1200\/JCO.1997.15.6.2442","article-title":"Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy","volume":"15","author":"van Basten","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB178","first-page":"224","article-title":"Gonadal function in men with testicular cancer","volume":"25","author":"Petersen","year":"1998","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB179","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.1999.17.3.941","article-title":"Semen quality and reproductive hormones before orchiectomy in men with testicular cancer","volume":"17","author":"Petersen","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB180","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1200\/JCO.1999.17.5.1493","article-title":"Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency","volume":"17","author":"Howell","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB181","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0277-5379(90)90010-Q","article-title":"Children fathered by men treated with chemotherapy for testicular cancer","volume":"26","author":"Senturia","year":"1990","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB182","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/jnci\/85.1.36","article-title":"Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols","volume":"85","author":"Nichols","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB183","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/oxfordjournals.annonc.a059037","article-title":"Secondary tumours following etoposide containing therapy for germ cell cancer","volume":"6","author":"Boshoff","year":"1995","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB184","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/85.1.60","article-title":"Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy","volume":"85","author":"Bajorin","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB185","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0140-6736(91)90490-G","article-title":"Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours","volume":"338","author":"Pedersen-Bjergaard","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB186","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1200\/JCO.1998.16.10.3386","article-title":"Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors","volume":"16","author":"Kollmannsberger","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB187","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9343(90)90185-G","article-title":"Sarcoidosis, \u201csarcoid-like lymphadenopathy\u201d, and testicular germ cell tumors","volume":"89","author":"Toner","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB188","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1008253323854","article-title":"Late relapse of germ cell tumors after cisplatin-based chemotherapy","volume":"8","author":"Gerl","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2004.05.006_BIB189","doi-asserted-by":"crossref","unstructured":"ESMO. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of testicular seminoma. Ann Oncol 2001;12:1217\u20138.","DOI":"10.1023\/A:1012416707128"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842804001039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842804001039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T10:21:48Z","timestamp":1624530108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842804001039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":189,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1040842804001039"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2004.05.006","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}